Status:
COMPLETED
Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation
Lead Sponsor:
Logical Therapeutics
Conditions:
Healthy
Eligibility:
All Genders
45-70 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare naproxen plasma levels and gastroduodenal mucosal injury after administration of LT-NS001 as compared to Naprosyn in subjects age 45-70.
Eligibility Criteria
Inclusion
- BMI 18-30 kg/m2
- No NSAID's for 14 days prior to baseline endoscopy
Exclusion
- Pregnant/Nursing women
- History of documented gastroduodenal ulcer
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00750243
Start Date
September 1 2008
End Date
April 1 2009
Last Update
October 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612